A Randomized, Open-Label Study of the Efficacy and Safety of AZD4547 Monotherapy vs Paclitaxel for the Treatment of Advanced Gastric Adenocarcinoma With FGFR2 Polysomy or Gene Amplification29. This evidence concerns the gene FGFR2 and gastric adenocarcinoma.